Literature DB >> 18060044

Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP.

Ho-Jin Park1, Serban P Georgescu, Chuang Du, Christopher Madias, Mark J Aronovitz, C Michael Welzig, Bo Wang, Ulrike Begley, Yali Zhang, Robert O Blaustein, Richard D Patten, Richard H Karas, Herbert H Van Tol, Timothy F Osborne, Hitoshi Shimano, Ronglih Liao, Mark S Link, Jonas B Galper.   

Abstract

Parasympathetic stimulation of the heart, which provides protection from arrhythmias and sudden death, involves activation of the G protein-coupled inward rectifying K+ channel GIRK1/4 and results in an acetylcholine-sensitive K+ current, I KACh. We describe a unique relationship between lipid homeostasis, the lipid-sensitive transcription factor SREBP-1, regulation of the cardiac parasympathetic response, and the development of ventricular arrhythmia. In embryonic chick atrial myocytes, lipid lowering by culture in lipoprotein-depleted serum increased SREBP-1 levels, GIRK1 expression, and I KACh activation. Regulation of the GIRK1 promoter by SREBP-1 and lipid lowering was dependent on interaction with 2 tandem sterol response elements and an upstream E-box motif. Expression of dominant negative SREBP-1 (DN-SREBP-1) reversed the effect of lipid lowering on I KACh and GIRK1. In SREBP-1 knockout mice, both the response of the heart to parasympathetic stimulation and the expression of GIRK1 were reduced compared with WT. I KACh, attenuated in atrial myocytes from SREBP-1 knockout mice, was stimulated by SREBP-1 expression. Following myocardial infarction, SREBP-1 knockout mice were twice as likely as WT mice to develop ventricular tachycardia in response to programmed ventricular stimulation. These results demonstrate a relationship between lipid metabolism and parasympathetic response that may play a role in arrhythmogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18060044      PMCID: PMC2104475          DOI: 10.1172/JCI32011

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans.

Authors:  M S Brown; J Ye; R B Rawson; J L Goldstein
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  Sterol regulation of human fatty acid synthase promoter I requires nuclear factor-Y- and Sp-1-binding sites.

Authors:  S Xiong; S S Chirala; S J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  TGFbeta regulates the expression of G alpha(i2) via an effect on the localization of ras.

Authors:  Simone M Ward; Albert P Gadbut; Dongjiang Tang; Alexander G Papageorge; Leeying Wu; Guangde Li; Joey V Barnett; Jonas B Galper
Journal:  J Mol Cell Cardiol       Date:  2002-09       Impact factor: 5.000

4.  Transforming growth factor beta (TGFbeta ) signaling via differential activation of activin receptor-like kinases 2 and 5 during cardiac development. Role in regulating parasympathetic responsiveness.

Authors:  Simone M Ward; Jay S Desgrosellier; Xiaoli Zhuang; Joey V Barnett; Jonas B Galper
Journal:  J Biol Chem       Date:  2002-10-21       Impact factor: 5.157

5.  Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.

Authors:  Jeffrey J Goldberger; Haris Subacius; Andi Schaechter; Adam Howard; Ronald Berger; Alaa Shalaby; Joseph Levine; Alan H Kadish
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

6.  Focal modification of electrical conduction in the heart by viral gene transfer.

Authors:  J K Donahue; A W Heldman; H Fraser; A D McDonald; J M Miller; J J Rade; T Eschenhagen; E Marbán
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

7.  Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; L DiCarlo; M R Gold; G S Greer; E N Prystowsky; M F O'Toole; A Tang; J D Fisher; J Coromilas; M Talajic; G Hafley
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

8.  Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients.

Authors:  J De Sutter; R Tavernier; M De Buyzere; L Jordaens; G De Backer
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

Review 9.  Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology.

Authors:  Richard G W Anderson
Journal:  Trends Cell Biol       Date:  2003-10       Impact factor: 20.808

10.  Role of sterol regulatory element binding proteins in the regulation of Galpha(i2) expression in cultured atrial cells.

Authors:  Ho-Jin Park; Ulrike Begley; Dequan Kong; Haiyan Yu; Liya Yin; F Bradley Hillgartner; Timothy F Osborne; Jonas B Galper
Journal:  Circ Res       Date:  2002-07-12       Impact factor: 17.367

View more
  19 in total

1.  Fatty acid synthase modulates homeostatic responses to myocardial stress.

Authors:  Babak Razani; Haixia Zhang; P Christian Schulze; Joel D Schilling; John Verbsky; Irfan J Lodhi; Veli K Topkara; Chu Feng; Trey Coleman; Attila Kovacs; Daniel P Kelly; Jeffrey E Saffitz; Gerald W Dorn; Colin G Nichols; Clay F Semenkovich
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 2.  Developmental and extrahepatic physiological functions of SREBP pathway genes in mice.

Authors:  Luke J Engelking; Mary Jo Cantoria; Yanchao Xu; Guosheng Liang
Journal:  Semin Cell Dev Biol       Date:  2017-07-20       Impact factor: 7.727

3.  The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein.

Authors:  Hidekazu Takeuchi; Masataka Sata
Journal:  Heart Asia       Date:  2012-01-01

4.  Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif.

Authors:  Young-Kyo Seo; Hansook Kim Chong; Aniello M Infante; Seung-Soon Im; Xiaohui Xie; Timothy F Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

5.  Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries.

Authors:  Changiz Taghibiglou; Henry G S Martin; Ted Weita Lai; Taesup Cho; Shiv Prasad; Luba Kojic; Jie Lu; Yitao Liu; Edmund Lo; Shu Zhang; Julia Z Z Wu; Yu Ping Li; Yan Hua Wen; Joon-Hyuk Imm; Max S Cynader; Yu Tian Wang
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

Review 6.  Expanding roles for SREBP in metabolism.

Authors:  Wei Shao; Peter J Espenshade
Journal:  Cell Metab       Date:  2012-09-20       Impact factor: 27.287

7.  Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice.

Authors:  Ho-Jin Park; Yali Zhang; Chuang Du; C Michael Welzig; Christopher Madias; Mark J Aronovitz; Serban P Georgescu; Isaac Naggar; Bo Wang; Young-Bum Kim; Robert O Blaustein; Richard H Karas; Ronglih Liao; Clayton E Mathews; Jonas B Galper
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

8.  Increased inducibility of ventricular tachycardia and decreased heart rate variability in a mouse model for type 1 diabetes: effect of pravastatin.

Authors:  Mohammad Rajab; Hongwei Jin; Charles M Welzig; Alfred Albano; Mark Aronovitz; Yali Zhang; Ho-Jin Park; Mark S Link; Sami F Noujaim; Jonas B Galper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

9.  Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.

Authors:  Traci L Parry; Gopal Desai; Jonathan C Schisler; Luge Li; Megan T Quintana; Natalie Stanley; Pamela Lockyer; Cam Patterson; Monte S Willis
Journal:  Cardiovasc Pathol       Date:  2015-10-29       Impact factor: 2.185

10.  The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics.

Authors:  Zia Zuberi; Lutz Birnbaumer; Andrew Tinker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-01       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.